Metaphase cytogenetics adds to gene expression profiling in the identification of high risk multiple myeloma.

被引:0
|
作者
Tricot, Guido
Zhan, Fenghuang
Barlogie, Bart
Huang, Yongsheng
Sawyer, Jeffrey
Shaughnessy, John
机构
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
114
引用
收藏
页码:38A / 38A
页数:1
相关论文
共 50 条
  • [1] Osteoclast Gene Expression Profiling in Multiple Myeloma.
    Moreaux, Jerome
    Hose, Dirk
    Reme, Thierry
    Moine, Philippe
    Mahtouk, Karene
    Moos, Marion
    Requirand, Guilhem
    De Vos, John
    Rossi, Jean Francois
    Goldschmidt, Hartmut
    Klein, Bernard
    [J]. BLOOD, 2008, 112 (11) : 945 - 945
  • [2] Integrating cytogenetics and gene expression profiling in the molecular analysis of Multiple Myeloma
    John D. Shaughnessy
    Bart Barlogie
    [J]. International Journal of Hematology, 2002, 76 : 59 - 64
  • [3] Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myeloma
    Shaughnessy, JD
    Barlogie, B
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 2) : 59 - 64
  • [4] Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
    Mellors, Patrick
    Binder, Moritz
    Ketterling, Rhett P.
    Griepp, Patricia
    Baughn, Linda B.
    Buadi, Francis K.
    Lacy, Martha Q.
    Gertz, Morie A.
    Dispenzieri, Angela
    Haymann, Suzanne
    Kapoor, Prashant
    Gonsalves, Wilson I.
    Hwa, Yi Lisa
    Fonder, Amie
    Hobbs, Miriam A.
    Kourelis, Taxiarchis
    Warsame, Rahma M.
    Lust, John A.
    Leung, Nelson
    Go, Ronald S.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    [J]. BLOOD, 2019, 134
  • [5] Gene expression profiles in multiple myeloma.
    Magrangeas, F
    Avet-Loiseau, H
    Nasser, V
    Doriot, B
    Nguyen, C
    Houlgatte, R
    Bataille, R
    Minvielle, S
    [J]. BLOOD, 2001, 98 (11) : 733A - 733A
  • [6] Cytogenetics in newly diagnosed multiple myeloma.
    Testoni, N
    Ruggeri, D
    Tosi, P
    Carboni, C
    Iacurti, E
    Martinelli, G
    Ronconi, S
    Cavo, M
    Tura, S
    [J]. BLOOD, 1999, 94 (10) : 306B - 306B
  • [7] Toward the molecular classification of myeloma: Gene expression profiling in the diagnosis, prognosis, and treatment of multiple myeloma.
    Zhan, F
    Bumm, K
    Tian, E
    Xu, H
    Zangari, M
    Desikan, R
    Badros, A
    Morris, C
    Toor, A
    Anaissie, E
    Tricot, G
    Barlogie, B
    Shaughnessy, J
    [J]. LEUKEMIA, 2001, 15 (03) : 493 - 493
  • [8] Abnormal Metaphase Cytogenetics Adds to Currently Known Risk-Factors for Venous Thromboembolism in Multiple Myeloma: Derivation of the PRISM score
    Chakraborty, Rajshekhar
    Rybicki, Lisa
    Valent, Jason
    Garcia, Alex V. Mejia
    Faiman, Beth M.
    Khouri, Jack
    Rosko, Nathaniel
    Samaras, Christy J.
    Kalaycio, Matt
    Anwer, Faiz
    Khorana, Alok A.
    [J]. BLOOD, 2020, 136
  • [9] Gene Expression Profiling of Structural and Functional High-Risk Multiple Myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    Haug, Jessica L.
    Dispenzieri, Angela
    Henderson, Kimberly J.
    Kimlinger, Teresa K.
    Stewart, A. Keith
    Bergsagel, P. Leif
    Kumar, Shaji K.
    [J]. BLOOD, 2019, 134
  • [10] High-Risk Multiple Myeloma Patients Are Missed without Gene Expression Profiling
    Van Vliet, Martin H.
    Chen, Yan-Ting
    Van Beers, Erik H.
    Kuiper, Rowan
    Valent, Erik T.
    Spaan, Marieke
    Terragna, Carolina
    Zamagni, Elena
    Cavo, Michele
    Oliva, Stefania
    Larocca, Alessandra
    Haferlach, Torsten
    Chng, Wee-Joo
    Waage, Anders
    Duin, M.
    Sonneveld, Pieter
    [J]. BLOOD, 2020, 136